Emerald Clinical Trials

Highly Engaged Employees

Emerald Clinical Trials, founded in 2000 and strategically headquartered in Singapore, operates as a premier global clinical research organization. The company delivers comprehensive, end-to-end clinical trial services tailored for biopharmaceutical, medical device, and diagnostic sectors across all trial phases. Previously recognized as George Clinical, the organization underwent a significant rebranding in April 2025 to Emerald Clinical Trials, reflecting its substantial growth and unwavering dedication to fostering certainty and transparency within the complex landscape of global clinical research.

Boasting over 25 years of specialized experience, Emerald Clinical Trials has established a formidable international footprint. The organization employs over 500 professionals across 40 geographical locations, spanning key regions such as Asia-Pacific, North America, and Europe. Emerald Clinical Trials actively collaborates with more than 100 biotech firms and six of the world's top ten pharmaceutical companies. The company possesses renowned expertise in renal research, having successfully led over 80 renal studies in 50 countries, alongside robust capabilities in oncology and cardio-renal-metabolic therapeutic areas.

Emerald Clinical Trials provides a full spectrum of essential services, including regulatory affairs, clinical trial monitoring, patient recruitment, data management, and safety reporting. The organization champions patient-centered trial design and diverse population recruitment, leveraging deep local expertise to expedite study completion and ensure high-quality, reliable outcomes. Their overarching mission is to accelerate medical innovation and deliver life-changing therapies to patients worldwide. To learn more about the dedicated professionals driving these advancements, Meet Emerald Clinical Trials's team. The company reports revenue of $105.7M and operates with a workforce of 500-1,000 employees.